2020/04/29 | Press Release – Growth investment is set to accelerate Polyplus’ expansion in partnership with Warburg Pincus and ArchiMed
Warburg Pincus brings strong healthcare experience and a global network to support innovation and scale-up as Polyplus serves the gene and cell therapy market. Illkirch, FRANCE, April 29, 2020 –– Polyplus-transfection® SA (“Polyplus”), a developer of innovative and cost-effective technology used in gene and cell therapy, closed on a major investment from Warburg Pincus, a…